Open Access. Powered by Scholars. Published by Universities.®
- Institution
- Keyword
-
- Chronic kidney disease (3)
- Dialysis (3)
- Humans (3)
- Oregon (3)
- Oregon gme (3)
-
- Acute kidney injury (2)
- Child (2)
- Depression (2)
- Hepatorenal syndrome (2)
- Kidney (2)
- Nephrology (2)
- Oregon; ppmc; ppmc gme (2)
- Pediatric nephrology (2)
- Safety (2)
- ACGME (1)
- Accreditation (1)
- Adiposity (1)
- Adolescent (1)
- Adult (1)
- Adverse Effects (1)
- Africa (1)
- Albumin (1)
- Alopecia (1)
- Anecdotal (1)
- Anxiety (1)
- Ascites (1)
- Atherosclerosis (1)
- Bisphosphonates (1)
- Body Water (1)
- Burnout (1)
- Publication
-
- Clinical Research in Practice: The Journal of Team Hippocrates (6)
- Research Days (5)
- Books, Presentations, Posters, Etc. (3)
- Manuscripts, Articles, Book Chapters and Other Papers (3)
- Digital Journal of Clinical Medicine (2)
-
- Poster Presentations (2)
- SOMA Faculty Publications (2)
- St. Joseph Hospital, Orange, CA. Evidence Based Practice Conference (2)
- Articles, Abstracts, and Reports (1)
- Doctoral Projects (1)
- Faculty, Staff and Students Publications (1)
- Providence Pharmacy PGY1 Program at Providence Portland and Providence St. Vincent Medical Centers 2023 (1)
- Student Scholarly Projects (1)
- View All Graduate Medical Education Content (1)
- Publication Type
Articles 31 - 31 of 31
Full-Text Articles in Nephrology
It Is Reasonable To Treat Patients With Type 1 Hepatorenal Syndrome With Midodrine And Octreotide, William Kane
It Is Reasonable To Treat Patients With Type 1 Hepatorenal Syndrome With Midodrine And Octreotide, William Kane
Clinical Research in Practice: The Journal of Team Hippocrates
A critical appraisal and clinical application of Esrailian E, Pantangco ER, Kyulo NL, Hu KQ, Runyon BA. Octreotide/midodrine therapy significantly improves renal function and 30-day survival in patients with type 1 hepatorenal syndrome. Dig Dis Sci. 2007;52(3):742-748. doi: 10.1007/s10620-006-9312-0